ALHYG.PA
Price:
$0.0103
Market Cap:
$3.95M
Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, France. Hybrigenics SA is a subsidiary of Diagnostic Medical Systems S.A.[Read more]
Industry
Biotechnology
IPO Date
2007-12-28
Stock Exchange
EURONEXT
Ticker
ALHYG.PA
According to Hybrigenics SA’s latest financial reports and current stock price. The company's current ROE is -679.52%. This represents a change of 50.79% compared to the average of -1.34% of the last 4 quarters.
The mean historical ROE of Hybrigenics SA over the last ten years is -40.15%. The current -679.52% ROE has changed 1.59% with respect to the historical average. Over the past ten years (40 quarters), ALHYG.PA's ROE was at its highest in in the December 2011 quarter at 93.20%. The ROE was at its lowest in in the June 2018 quarter at -2033.33%.
Average
-40.15%
Median
-22.13%
Minimum
-587.33%
Maximum
402.20%
Discovering the peaks and valleys of Hybrigenics SA ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 576.05%
Maximum Annual ROE = 402.20%
Minimum Annual Increase = -7402.81%
Minimum Annual ROE = -587.33%
Year | ROE | Change |
---|---|---|
2023 | 402.20% | -7402.81% |
2022 | -5.51% | -275.03% |
2021 | 3.15% | -146.88% |
2020 | -6.71% | -61.97% |
2019 | -17.65% | -96.99% |
2018 | -587.33% | 576.05% |
2017 | -86.88% | 78.56% |
2016 | -48.65% | 76.85% |
2015 | -27.51% | 3.35% |
2014 | -26.62% | -64.11% |
The current ROE of Hybrigenics SA (ALHYG.PA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
133.28%
5-year avg
75.09%
10-year avg
-40.15%
Hybrigenics SA’s ROE is greater than Neovacs S.A. (-123.46%), less than Biophytis S.A. (294.01%), greater than Innate Pharma S.A. (-84.39%), less than Nanobiotix S.A. (283.43%), less than Adocia SA (360.25%),
Company | ROE | Market cap |
---|---|---|
-123.46% | $446.08K | |
294.01% | $2.27M | |
-84.39% | $115.43M | |
283.43% | $136.81M | |
360.25% | $113.64M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hybrigenics SA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hybrigenics SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Hybrigenics SA's ROE?
How is the ROE calculated for Hybrigenics SA (ALHYG.PA)?
What is the highest ROE for Hybrigenics SA (ALHYG.PA)?
What is the 3-year average ROE for Hybrigenics SA (ALHYG.PA)?
What is the 5-year average ROE for Hybrigenics SA (ALHYG.PA)?
How does the current ROE for Hybrigenics SA (ALHYG.PA) compare to its historical average?